The Association between ACTN3 R577X Polymorphism and Range of Motion: A Systematic Review and Meta-analysis.

Mika Saito, Hirofumi Zempo, Kathleen Yasmin de Almeida, Hiroki Homma, Naoki Kikuchi

Journal: International journal of sports medicine 2023;44(9):618-624

PMID: 36787803

Abstract

The R577X polymorphism in the α-actinin-3 gene () is associated with muscle strength and power; there is an association between R577X polymorphism and range of motion (ROM). We examined the effect of the R577X polymorphism on ROM through meta-analysis and systematic review. Relevant studies published before April 14, 2022 were identified from the PubMed database using the following keywords and Boolean operators: ("flexibility" or "Joint Range of Motion" or "Joint Flexibility" or "Range of motion") and ("ACTN3" or "alpha-actinin 3"). Studies that met the following criteria were included: (1) published in English, (2) included human subjects, (3) provided ROM measurements, and (4) analyzed the R577X genotype. A total of 2908 participants from seven studies were included in the meta-analysis. The additive genetic model was assessed using a meta-regression model, and dominant and recessive models were analyzed using a random effects model. The ROM in the XX+RX genotype was significantly higher than that in the RR genotype (recessive model: p<0.001), and it increased additively in the order XX>RX>RR (additive model: p=0.029). However, no significant association was observed in the dominant model. These findings further elucidate the association between flexibility and the R577X genotype.

Thieme. All rights reserved.

Address: Graduate School of Health and Sport Science, Nippon Sport Science University, Setagaya-ku, Japan.; Faculty of Health and Nutrition, Tokyo Seiei College, Katsushika-ku, Japan.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.